Nuclear morphometric study of prostatic atrophy

1. Herawi, M., Parwani, A.V., Irie, J. & Epstein, J.I. (2005). Small glandular proliferations on needle biopsies: most common benign mimickers of prostatic adenocarcinoma sent in for expert second opinion. Am J Surg Pathol. 29, 874-88010.1097/01.pas.0000159520.36806.3eSearch in Google Scholar

2. Prando, A. & Billis, A. (2009). Focal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studies. Abdom Imaging. 34, 271-27510.1007/s00261-008-9382-xSearch in Google Scholar

3. De Marzo, A.M., Marchi, V.L., Epstein, J.I. & Nelson, W.G. (1999). Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 155, 1985-92Search in Google Scholar

4. van Leenders, G.J., Gage, W.R., Hicks, J.L., van Balken, B., Aalders, T.W. & Schalken, J.A. et al. (2003). Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol. 162, 1529-3710.1016/S0002-9440(10)64286-1Search in Google Scholar

5. Putzi, M.J. & De Marzo, A.M. (2000). Morphologic transitions between proliferative inflammatory atrophy and highgrade prostatic intraepithelial neoplasia. Urology. 56, 828-3210.1016/S0090-4295(00)00776-7Search in Google Scholar

6. De Marzo, A.M., Meeker, A.K., Zha, S., Luo, J., Nakayama, M. & Platz, E.A. et al. (2003). Human prostate cancer precursors and pathobiology. Urology. 62(5 Suppl. 1), 55-6210.1016/j.urology.2003.09.053Search in Google Scholar

7. Wang, W., Bergh, A. & Damber, J.E. (2009). Morphological transition of proliferative inflammatory atrophy to high grade intraepithelial neoplasia and cancer in human prostate. Prostate. 69, 1378-8610.1002/pros.20992Search in Google Scholar

8. Billis, A. (2010). Prostatic atrophy. Clinicopathological significance. Int Braz J Urol. 36(4), 401-9Search in Google Scholar

9. Veltri, R.W., Partin, A.W. & Miller, M.C. (2000). Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterations. J Cell Biochem Suppl. Suppl 35, 151-710.1002/1097-4644(2000)79:35+<151::AID-JCB1139>3.0.CO;2-7Search in Google Scholar

10. Montironi, R. (2001). Prognostic factors in prostate cancer. BMJ. 322, 378-37910.1136/bmj.322.7283.378Search in Google Scholar

11. Gardner, W.A. Jr. & Culberson, D.E. (1987). Atrophy and proliferation in the young adult prostate. J Urol. 137, 53-5610.1016/S0022-5347(17)43869-9Search in Google Scholar

12. Epstein, J.I., Walsh, P.C. & Sanfilippo, F. (1996). Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy. Am J Surg Pathol. 20, 851-85710.1097/00000478-199607000-00008Search in Google Scholar

13. Epstein, J.I. & Netto, G.J. (2008). Biopsy Interpretation of the prostate. Fourth edition - Lippincott Williams & Wilkins.Search in Google Scholar

14. Srigley, J.R. (2004). Benign mimickers of prostatic adenocarcinoma. Modern Pathology. 17, 328-34810.1038/modpathol.380005514976539Search in Google Scholar

15. Hedrick, L. & Epstein, J.I. (1989). Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma Am J Surg Pathol . 13, 389 - 396Search in Google Scholar